| Literature DB >> 30959759 |
You Luo1, Bin Peng2, Weiqian Wei3,4, Xiaofei Tian5, Zhenqiang Wu6.
Abstract
Guava (Psidium guajava L., Myrtaceae) leaves have been used as a folk herbal tea to treat diabetes for a long time in Asia and North America. In this study, we isolated polysaccharides from guava leaves (GLP), and evaluated its antioxidant activity in vitro and anti-diabetic effects on diabetic mice induced by streptozotocin combined with high-fat diet. The results indicated that GLP exhibited good DPPH, OH, and ABTS free-radical scavenging abilities, and significantly lowered fasting blood sugar, total cholesterol, total triglycerides, glycated serum protein, creatinine, and malonaldehyde. Meanwhile, it significantly increased the total antioxidant activity and superoxide dismutase (SOD) enzyme activity in diabetic mice, as well as ameliorated the damage of liver, kidney, and pancreas. Thus, polysaccharides from guava leaves could be explored as a potential antioxidant or anti-diabetic agents for functional foods or complementary medicine.Entities:
Keywords: anti-diabetic; antioxidant; guava leaves; polysaccharides
Mesh:
Substances:
Year: 2019 PMID: 30959759 PMCID: PMC6479919 DOI: 10.3390/molecules24071343
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1HPLC chromatograms of guava leave (GLP).
The antioxidant activities of GLP.
| IC50/μg/mL | GLP | Positive Control |
|---|---|---|
| DPPH assay | 46.49 ± 0.22 | 7.03 ± 0.15 |
| OH assay | 175.52 ± 0.31 | 119.37 ± 0.24 |
| ABTS assay | 102.82 ± 0.26 | 19.82 ± 0.11 |
Figure 2The body weight of mice in 5 weeks after modeling. NG, normal group; MG, model group; PG, positive group; LP, low-dose polysaccharides group; HP, high-dose polysaccharides group. “##” represents very significant difference compared with NG (p < 0.01); ** represents very significant difference compared with MG (p < 0.01); * represents significant difference compared with MG (p < 0.05).
Figure 3The fasting blood glucose of mice in 5 weeks after modeling.
Regulation effects of polysaccharides on biochemical indicators.
| Group | TC (mM) | TG (mM) | CRE (μM) | GSP (mM) | T-AOC (mM) | T-SOD (U/mgprot) | MDA (nmol/mgprot) |
|---|---|---|---|---|---|---|---|
| NG | 2.71 ± 0.24 | 0.75 ± 0.14 | 9.43 ± 0.86 | 1.99 ± 0.11 | 0.84 ± 0.04 | 796.52 ± 17.35 | 6.94 ± 0.29 |
| MG | 6.71 ± 0.90 ## | 2.18 ± 0.30 ## | 22.52 ± 3.60 ## | 3.07 ± 0.15 ## | 0.55 ± 0.03 ## | 608.95 ± 24.73 ## | 12.50 ± 1.42 ## |
| PG | 5.36 ± 0.51 ** | 1.76 ± 0.12 ** | 13.26 ± 1.21 ** | 2.48 ± 0.09 ** | 0.68 ± 0.02 ** | 721.83 ± 32.66 ** | 9.11 ± 0.35 ** |
| LP | 4.52 ± 0.63 ** | 1.35 ± 0.22 ** | 14.19 ± 1.14 ** | 2.85 ± 0.18 ** | 0.70 ± 0.01 ** | 702.13 ± 11.76 ** | 9.75 ± 0.37 ** |
| HP | 3.98 ± 0.35 ** | 1.32 ± 0.16 ** | 13.28 ± 1.04 ** | 2.43 ± 0.15 ** | 0.75 ± 0.02 ** | 730.80 ± 12.98 ** | 8.99 ± 0.26 ** |
## represents very significant difference compared with NG (p < 0.01); ** represents very significant difference compared with MG (p < 0.01).
Figure 4Liver histology images (HE staining, 100×). (a) NG; (b) MG; (c) PG; (d) LP; (e) HP.
Figure 5Kidney histology images (HE staining, 100×). (a) NG; (b) MG; (c) PG; (d) LP; (e) HP.
Figure 6Pancreas histology images (HE staining, 100×). (a) NG; (b) MG; (c) PG; (d) LP; (e) HP.